Insight Molecular Diagnostics Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
Insight Molecular Diagnostics Inc. (IMDX) reported Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit of $2.12 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit · last filed 2022-03-11
- Insight Molecular Diagnostics Inc. share-based payment arrangement, option, exercise price range, lower range limit for the quarter ending 2019-03-31 was $2.30.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2021 was $2.12, a 59.40% increase from fiscal 2020.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2020 was $1.33, a 0.75% decline from fiscal 2019.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2019 was $1.34, a 41.74% decline from fiscal 2018.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2018 was $2.30.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 3 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 6 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 9 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 12 month |
|---|---|---|---|---|
| 2021-12-31 | $2.12 10-K · filed 2022-03-11 | |||
| 2020-12-31 | $1.33 10-K · filed 2021-03-19 | |||
| 2019-12-31 | $1.34 10-K · filed 2020-03-26 | |||
| 2019-03-31 | $2.30 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | $2.30 10-K · filed 2019-04-01 | |||
| 2018-09-30 | $2.35 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | $2.35 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |